Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices

• Główni autorzy: Bożena Szyguła-Jurkiewicz (Autor), Wioletta Szczurek-Wasilewicz (Autor), Mariusz Gąsior (Autor), Izabela Copik (Autor), Justyna Małyszek-Tumidajewicz (Autor), Michał Skrzypek (Autor), Ewa Romuk (Autor), Michał Zembala (Autor), Marian Zembala (Autor), Piotr Przybyłowski (Autor)
• Format: Książka
• Wydane: MDPI AG, 2021-11-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Left ventricular assist device (LVAD) is well established as an alternative treatment for end-stage heart failure (HF) patients. The aim of the study was to determine the prognostic value of oxidative stress markers and the modified Model for End-Stage Liver Disease (modMELD) in patients receiving b...